Should Dukes' B patients receive adjuvant therapy? A statistical perspective

被引：79

作者：

Buyse, M

Piedbois, P

机构：

[1] Int Inst Drug Dev, B-1050 Brussels, Belgium

[2] Limburgs Univ Ctr, Dept Biostat, Diepenbeek, Belgium

[3] Hop Henri Mondor, Dept Oncol, F-94010 Creteil, France

[4] European Assoc Res Oncol, Creteil, France

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 01期

关键词：

D O I：

10.1053/sonc.2001.19727

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：20 / 24

页数：5

共 12 条

[1] Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer [J].

Erlichman, C ;

O'Connell, M ;

Kahn, M ;

Marsoni, S ;

Torri, V ;

Tardio, B ;

Zaniboni, A ;

Pancera, G ;

Martignoni, G ;

Labianca, R ;

Barni, A ;

Seitz, JF ;

Milan, C ;

Bedenne, L ;

Giovannini, M ;

Letreut, YP ;

Skillings, J ;

Shepard, L ;

Zee, B ;

Petrioli, R ;

Francini, G .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1356-1363

[2] FOLINIC ACID AND 5-FLUOROURACIL AS ADJUVANT CHEMOTHERAPY IN COLON-CANCER [J].

FRANCINI, G ;

PETRIOLI, R ;

LORENZINI, L ;

MANCINI, S ;

ARMENIO, S ;

TANZINI, G ;

MARSILI, S ;

AQUINOA ;

MARZOCCA, G ;

CIVITELLI, S ;

MARIANI, L ;

DESANDO, D ;

BOVENGA, S ;

LORENZI, M .

GASTROENTEROLOGY, 1994, 106 (04) :899-906

[3]

Gray R, 1997, JNCI-J NATL CANCER I, V89, P497

[4]

Gray RG, 2000, LANCET, V355, P1588

[5]

LABIANCA R, 1995, LANCET, V345, P939

[6] Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' c colon cancer: Results from four national surgical adjuvant breast and bowel project adjuvant studies (C-01, C-02, C-03, and C-04) [J].

Mamounas, E ;

Wieand, S ;

Wolmark, N ;

Bear, HD ;

Atkins, JN ;

Song, K ;

Jones, J ;

Rockette, H .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1349-1355

[7] LEVAMISOLE AND FLUOROURACIL FOR ADJUVANT THERAPY OF RESECTED COLON-CARCINOMA [J].

MOERTEL, CG ;

FLEMING, TR ;

MACDONALD, JS ;

HALLER, DG ;

LAURIE, JA ;

GOODMAN, PJ ;

UNGERLEIDER, JS ;

EMERSON, WA ;

TORMEY, DC ;

GLICK, JH ;

VEEDER, MH ;

MAILLIARD, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) :352-358

[8] Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer [J].

OConnell, MJ ;

Mailliard, JA ;

Kahn, MJ ;

MacDonald, JS ;

Haller, DG ;

Mayer, RJ ;

Wieand, HS .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :246-250

[9] POSTOPERATIVE ADJUVANT CHEMOTHERAPY OR BCG FOR COLON CANCER - RESULTS FROM NSABP PROTOCOL-C-01 [J].

WOLMARK, N ;

FISHER, B ;

ROCKETTE, H ;

REDMOND, C ;

WICKERHAM, DL ;

FISHER, ER ;

JONES, J ;

GLASS, A ;

LERNER, H ;

LAWRENCE, W ;

PRAGER, D ;

WEXLER, M ;

EVANS, J ;

CRUZ, A ;

DIMITROV, N ;

JOCHIMSEN, P .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (01) :30-36

[10] THE BENEFIT OF LEUCOVORIN-MODULATED FLUOROURACIL AS POSTOPERATIVE ADJUVANT THERAPY FOR PRIMARY COLON-CANCER - RESULTS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL C-03 [J].

WOLMARK, N ;

ROCKETTE, H ;

FISHER, B ;

WICKERHAM, DL ;

REDMOND, C ;

FISHER, ER ;

JONES, J ;

MAMOUNAS, EP ;

ORE, L ;

PETRELLI, NJ ;

SPURR, CL ;

DIMITROV, N ;

ROMOND, EH ;

SUTHERLAND, CM ;

KARDINAL, CG ;

DEFUSCO, PA ;

JOCHIMSEN, P .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) :1879-1887

← 1 2 →